Clonal origin tracing and integrated biomarker analysis in a JAK2V617F-positive essential thrombocythemia patient progressing to T-cell acute lymphoblastic leukemia
The study aims to trace the clonal origin and analyze biomarkers related to disease progression in a specific patient with JAK2V617F-positive essential thrombocythemia.
Conducted clonal origin tracing
Performed integrated biomarker analysis
Documented disease progression from essential thrombocythemia to T-cell acute lymphoblastic leukemia
Identified clonal lineage transition during progression
Noted significant biomarker changes associated with disease advancement
Abstract
Not available.
اسأل الذكاء الاصطناعي
Like
Bookmark
Share
View Full Paper
اسأل الذكاء الاصطناعي
Like
Bookmark
Share
View Full Paper
Clonal origin tracing and integrated biomarker analysis in a JAK2V617F-positive essential thrombocythemia patient progressing to T-cell acute lymphoblastic leukemia | Synapse